Instrument de mesure de la nausée chez l’enfant : traduction française et validité des visages pour les patients canadiens francophones en oncopédiatrie

Anne Choquette, Araby Sivananthan, Annie Guillemette, Erin O'Shaughnessy, Martha Pinheiro-Maltez, Linda MacKeigan, Anne-Marie Langevin, L. Lee Dupuis

Abstract


Les nausées et les vomissements induits par la chimiothérapie (NVIC) nuisent à la qualité de vie tant des adultes que des patients pédiatriques atteints d’un cancer (Dupuis, Milne-Wren, Cassidy et al., 2010; Farrell, Brearley, Pilling et Molassiotic, 2013; Russo, Cinausero, Gerratana et al., 2014; Hinds, Gattuso, Billups et al., 2009; Sommariva, Pongiglione, et Tarricone, 2016). Les vomissements et les haut-le-cœur sont des symptômes qui s’évaluent objectivement, alors que la nausée est subjective et plus difficile à mesurer. En général, l’intensité de la nausée chez les adultes peut être décrite à l’aide d’échelles d’évaluation visuelle analogique ou qualitative. Il existe à cette fin des instruments validés et recommandés par des spécialistes du domaine, comme celui de la Multinational Association of Supportive Care in Cancer (en ligne : www.mascc.org) (Hesketh, Gralla, du Bois et Tonato, 2016). 


Full Text:

PDF

References


Canadian General Standards Board. (2008). Translation Services. Gatineau: Standards Council of Canada.

Clinton, F., Dowling, M., & Capra, M. (2012). An audit of chemotherapy-induced nausea and vomiting in children. Nursing Children and Young People, 24, 18–23.

Dupuis, L. L., Boodhan, S., Sung, L., Portwine, C., Hain, R., McCarthy, P., Holdsworth, M., & Pediatric Oncology Group of Ontario (2011). Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients. Pediatr Blood Cancer, 57, 191–8.

Dupuis, L. L., Kelly, K. M., Krischer, J. P., Langevin, A. M., Tamura, R. N., Xu, P., Chen, L., Kolb, E. A., Ullrich, N. J., Sahler, O., Hendershot, E., Stratton, A., Sung, L., & McLean, T. W. (2018). Acupressure does not improve chemotherapy-induced nausea control in pediatric patients receiving highly emetogenic chemotherapy: A single blinded, randomized, controlled trial. Cancer, 124, 1188–96.

Dupuis, L. L., Lu, X., Mitchell, H. R., Sung, L., Devidas, M., Mattano, L. A., Jr, Carroll, W. L., Winick, N., Hunger, S. P., Maloney, K. W., & Kadan-Lottick, N. S. (2016). Anxiety, pain, and nausea during treatment of standard risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children’s Oncology Group. Cancer, 122, 1116–25.

Dupuis, L. L., Milne-Wren, C., Cassidy, M., Barrera, M., Portwine, C., Johnston, D. L., Silva, M. P., Sibbald, C., Leaker, M., Routh, S., & Sung, L. (2010). Symptom assessment in children receiving cancer therapy: The parents’ perspective. Support Care Cancer, 18, 281–99.

Dupuis, L. L., Taddio, A., Kerr, E. N., Kelly, A. & MacKeigan, L. (2006). Development and validation of a pediatric nausea assessment tool (PeNAT) for use by children receiving antineoplastic agents. Pharmacotherapy, 26, 1221–31.

Evans, A., Malvar, J., Garretson, C., Kolovos, E. P., & Baron Nelson, M. (2018). The use of aromatherapy to reduce chemotherapy-induced nausea in children with cancer: A randomized, double-blind, placebo-controlled trial. Journal of Pediatric Oncology Nursing, 35, 392–8.

Farrell, C., Brearley, S., Pilling, M., & Molassiotis, A. (2013).The impact of chemotherapy-related nausea on patients’ nutritional status, psychological distress and quality of life. Support Care Cancer, 21, 59–66.

Flank, J., Nadeem, K., Moledina, S., et al. (2017). Nausea and vomiting in children and adolescents receiving intrathecal methotrexate: A prospective, observational study. Pediatr Blood Cancer, 64, e26603.

Flank, J., Sparavalo, J., Vol, H., et al. (2017). The burden of chemotherapy-induced nausea and vomiting in children receiving hematopoietic stem cell transplantation conditioning: A prospective study. Bone Marrow Transplantation, 52, 1294–9.

Gilmore, J., Peacock, N., Gu, A., et al. (2014). Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE Study. Journal of Oncology Practice, 10, 68–74.

Hesketh, P., Bohlke, K., Lyman, G. H. et al. (2015). Antiemetics: American Society of Clinical Oncology focused guideline update. Journal of Clinical Oncology, 34(4), 381–6. https://doi.org/10.1200/JCO.2015.64.3635.

Hesketh, P. J., Gralla, R. J., du Bois, A., & Tonato, M. (1998). Methodology of antiemetic trials: Response assessment, evaluation of new agents and definition of chemotherapy emetogenicity. Support Care Cancer, 6, 221–7.

Hinds, P., Gattuso, J., Billups, C., et al. (2009). Aggressive treatment of non-metastatic osteosarcoma improves health-related quality of life in children and adolescents. European Journal of Cancer, 45, 2007–14.

McKinnon, K. & Jupp, J. (2019). Integration of a nausea and vomiting assessment tool into antineoplastic management of pediatric oncology patients. J Oncol Pharm Pract. https://doi.org/10.1177/1078155219892666

Patel, P., Lavoratore, S. R., Flank, J., et al. (2020). Chemotherapy-induced nausea and vomiting control in pediatric patients receiving ifosfamide plus etoposide: a prospective, observational study. Support Care Cancer, 28(2), 933–938. https://doi.org/10.1007/s00520-019-04903-0

Patel, P., Robinson, P., Thackray, J., et al. (2017). Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update. Pediatr Blood Cancer, 64, e26542.

Russo, S., Cinausero, M., Gerratana, L., et al. (2014). Factors affecting patient’s perception of anticancer treatments side-effects: An observational study. Expert opinion on drug safety, 13, 139–50.

Sommariva, S., Pongiglione, B., & Tarricone, R. (2016). Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: A systematic review. Critical reviews in oncology/hematology, 99, 13–36.

Sparavalo, J., Haggen, L., Chong, D., et al. (2012). Prevalence of chemotherapy-induced nausea and vomiting in children receiving hematopoietic stem cell transplantation conditioning. The Hospital for Sick Children.

Statistics Canada. (2016) Language Highlight Tables, 2016 Census. Government of Canada.

Txabarriaga, R. (2009). IMIA Guide on Medical Translation. International Medical Interpreters Association. https://www.imiaweb.org/

Vol, H., Flank, J., Lavoratore, S., et al. (2016). Poor chemotherapy-induced nausea and vomiting control in children receiving intermediate or high-dose methotrexate. Support Care Cancer, 24, 1365–71.

Willis, G. (2005). Cognitive interviewing: A tool for improving questionnaire design. Sage.


Refbacks

  • There are currently no refbacks.